智通财经APP获悉,香港联交所最新资料显示,4月15日,Sands Capital Management,LP减持泰格医药(03347)38.41万股,每股作价为25.9329港元,总金额约为996.08万港元。减持后最新持股数目为1089.6493万股,持股比例为8.85%。
本交易涉及其他关联方:Sands Capital Management,LLC;Sands Family Trust, LLC;Sands Frank Melville Jr.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.